Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oliver

Showing results (301-310 of 519) with videos related to

Pageof 52
Sort By:
BJU International|June 10, 2000
Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomyD Farrugia, W Ansell, M Singh, et al.
British Journal of Cancer|January 1, 1997
Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureterD Papamichael, C J Gallagher, R T Oliver, et al.
Progress in Clinical and Biological Research|January 1, 1984
Salvage cystectomy in the treatment of invasive bladder cancerJ P Blandy, H F Hope-Stone, R T Oliver, et al.
British Journal of Urology|July 1, 1988
Development of bladder tumour containing HPV type 11 DNA after renal transplantationG Querci della Rovere, R T Oliver, D J McCance, et al.
British Journal of Urology|January 1, 1988
Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumoursR T Oliver, H S Dhaliwal, H F Hope-Stone, et al.
European Journal of Immunology|July 1, 1989
Analysis of HLA antigens on germ cells in human semenA Jassim, W Ollier, A Payne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administrationM G Leahy, D Pitfield, S Popert, et al.
British Journal of Urology|September 1, 1996
The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancerA M Nouri, F Darakhshan, H Cannell, et al.
Urology|October 1, 1984
T3 bladder cancer: salvage rather than elective cystectomy after radiotherapyH F Hope-Stone, R T Oliver, H R England, et al.
British Journal of Cancer|December 6, 2000
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinomaC Mulatero, B R McClaren, M Mason, et al.
Pageof 52

Showing results (301-310 of 519) with videos related to

Sort By:
Pageof 52
BJU International|June 10, 2000
Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomyD Farrugia, W Ansell, M Singh, et al.
British Journal of Cancer|January 1, 1997
Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureterD Papamichael, C J Gallagher, R T Oliver, et al.
Progress in Clinical and Biological Research|January 1, 1984
Salvage cystectomy in the treatment of invasive bladder cancerJ P Blandy, H F Hope-Stone, R T Oliver, et al.
British Journal of Urology|July 1, 1988
Development of bladder tumour containing HPV type 11 DNA after renal transplantationG Querci della Rovere, R T Oliver, D J McCance, et al.
British Journal of Urology|January 1, 1988
Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumoursR T Oliver, H S Dhaliwal, H F Hope-Stone, et al.
European Journal of Immunology|July 1, 1989
Analysis of HLA antigens on germ cells in human semenA Jassim, W Ollier, A Payne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administrationM G Leahy, D Pitfield, S Popert, et al.
British Journal of Urology|September 1, 1996
The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancerA M Nouri, F Darakhshan, H Cannell, et al.
Urology|October 1, 1984
T3 bladder cancer: salvage rather than elective cystectomy after radiotherapyH F Hope-Stone, R T Oliver, H R England, et al.
British Journal of Cancer|December 6, 2000
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinomaC Mulatero, B R McClaren, M Mason, et al.
Pageof 52